(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Technical Communications Corporation, AMC, and BeiGene.

The three biggest losers today are Redhill Biopharma Ltd., Recon Technology, Ltd., and Quest Resource Holding Corporation.

Winners today

1. Technical Communications Corporation (TCCO) – 25%

Technical Communications Corporation engages in the design, development, manufacture, distribution, marketing, and sale of communications security devices, systems, and services worldwide. The company primarily provides data, video, fax, and voice networks. Its products include government systems, such as CSD 3324 SE secure telephone, fax and data system; CSD 3324 SP telephone and fax system; DSD 72A-SP military bulk ciphering system; and DSP 9000 radio encryption system, as well as the HSE 6000 squad radio headset and telephone encryptor for public safety special operations, land mobile radio applications, and for military applications. The company also provides network security systems comprising network encryption systems with centralized key and device management for IP, SONET/SDH, and frame relay networks to secure data in transit from local area network to local area network and across wide area networks. In addition, it offers secure office systems, such as CSD 4100 executive secure telephone and CipherTalk 8500 Internet protocol (IP)-based secure wireless phone. The company's products are used to protect confidentiality in communications between radios, landline telephones, mobile phones, facsimile machines, data network equipment over wires, fiber optic cables, radio waves, and microwave and satellite links. Further, it offers funded research and development, and technology development services. The company serves various markets, including foreign and domestic governmental agencies, law enforcement and military agencies, telecommunications carriers, financial institutions, and multinational companies requiring protection of mission-critical information. It sells directly to customers, original equipment manufacturers, and value-added resellers using its in-house sales force, as well as domestic and international representatives, consultants, and distributors. Technical Communications Corporation was founded in 1961 and is based in Concord, Massachusetts.

NASDAQ ended the session with Technical Communications Corporation jumping 25% to $1.00 on Thursday while NASDAQ rose 0.76% to $12,087.96.

Earnings Per Share

As for profitability, Technical Communications Corporation has a trailing twelve months EPS of $-1.39.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Technical Communications Corporation’s EBITDA is -6.27.

Revenue Growth

Year-on-year quarterly revenue growth declined by 71.3%, now sitting on 1M for the twelve trailing months.

More news about Technical Communications Corporation.

2. AMC (AMC) – 20.35%

AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. As of March 1, 2022, it operated approximately 950 theatres and 10,600 screens. The company was founded in 1920 and is headquartered in Leawood, Kansas.

NYSE ended the session with AMC jumping 20.35% to $4.87 on Thursday while NYSE jumped 0.07% to $15,379.13.

: AMC ‘continuing to evaluate next steps’ as judge denies request for quicker stock conversionAMC Entertainment Holdings Inc. said Thursday that it’s continuing to evaluate next steps after a judge into regular AMC shares, and while the two sides asked a judge to lift the status-quo order holding up the conversion, the judge said Wednesday that the parties offer no good cause to lift the order. , Unless and until the Court lifts the Status Quo Order, AMC will not proceed with filing the amendment to the company’s certificate of incorporation to effect the share increase and the reverse stock split previously approved by stockholders or the conversion of AMC Preferred Equity Units (APEs) into Class A common stock, the company said in a Thursday filing with the Securities and Exchange Commission.

AMC entertainment stock news: court dismisses APE conversionAMC Entertainment (AMC)stock spiked afterhours on Wednesday after news broke that the court considering CEO Adam Aron’s strategy of converting APE Preferred Equity units in AMC common stock ruled against lifting its status quo order. , Now, however, the Delaware Court of Chancery has halted the settlement that would have set up AMC to sell further equity and then pay off more of its heavy debt load.

Earnings Per Share

As for profitability, AMC has a trailing twelve months EPS of $-39.152.

Volume

Today’s last reported volume for AMC is 98405200 which is 162.84% above its average volume of 37438200.

Revenue Growth

Year-on-year quarterly revenue growth grew by 26.9%, now sitting on 4.09B for the twelve trailing months.

Previous days news about AMC

• AMC entertainment stock news: AMC loses 24%, APE gains 18% following conversion settlement. According to FXStreet on Tuesday, 4 April, "The agreement means that AMC can now move forward with expanding the limit on its pre-split common shares from "524,173,073 to 550,000,000 shares of Class A common stock" and its plan to effect a 1-for-10 reverse stock split. ", "More importantly, AMC shareholders will be further diluted by the conversion of APE Preferred Equity units into AMC stock. "

More news about AMC.

3. BeiGene (BGNE) – 12.85%

BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; Pamiparib for the treatment of various solid tumors; and Pobevcy to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC). The company's clinical stage drug candidates comprise Zanubrutinib, a BTK inhibitor to treat lymphomas; Tislelizumab, an anti-PD-1 antibody to treat solid and hematological cancers; Lifirafenib and BGB-3245 to treat melanoma, NSCLC, and endometrial cancer; and Sitravatinib, a multi-kinase inhibitor to treat NSCLC, melanoma, and other solid tumors. Its clinical stage drug candidates also include BGB-A333, a PD-L1 inhibitor to treat various solid tumors; Ociperlimab, a TIGIT inhibitor to treat various solid tumors; BGB-11417, a small molecule Bcl-2 inhibitor to treat mature B-cell malignancies; BGB-A445, an OX40 agonist antibody to treat solid tumors; Zanidatamab, a bispecific HER2 inhibitor to treat breast and gastric cancer; BGB-A425, a T-cell immunoglobulin and mucin-domain containing-3 inhibitor to treat various solid tumors; and BGB-15025, a small molecule inhibitor of HPK1. The company has strategic collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, and Bristol Myers Squibb company. BeiGene, Ltd. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with BeiGene rising 12.85% to $239.24 on Thursday, following the last session’s downward trend. NASDAQ rose 0.76% to $12,087.96, after three sequential sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, BeiGene has a trailing twelve months EPS of $-19.06.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -52.54%.

Sales Growth

BeiGene’s sales growth is 87.8% for the ongoing quarter and 86.4% for the next.

Volume

Today’s last reported volume for BeiGene is 561704 which is 140.86% above its average volume of 233206.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 21.1% and positive 30.7% for the next.

More news about BeiGene.

4. Novavax (NVAX) – 11.46%

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

NASDAQ ended the session with Novavax rising 11.46% to $8.46 on Thursday while NASDAQ rose 0.76% to $12,087.96.

Earnings Per Share

As for profitability, Novavax has a trailing twelve months EPS of $-7.27.

Volume

Today’s last reported volume for Novavax is 7432490 which is 16.46% above its average volume of 6381930.

Volatility

Novavax’s last week, last month’s, and last quarter’s current intraday variation average was 3.71%, 0.25%, and 3.91%.

Novavax’s highest amplitude of average volatility was 4.25% (last week), 3.06% (last month), and 3.91% (last quarter).

More news about Novavax.

5. SeaChange International (SEAC) – 10.73%

SeaChange International, Inc. provides multiscreen, advertising, and premium over the top (OTT) video products and services that facilitate the aggregation, licensing, management, and distribution of video and advertising content worldwide. The company offers video products, including video back-office, a software platform that enables content and service providers to manage, monetize and deliver a seamless viewing experience to subscribers across televisions, personal computers (PCs), tablets, smart phones, and other IP-enabled devices; and media asset management software, which is used to receive, manage and publish video content for viewing on televisions, tablets, PCs and other consumer devices. It also provides an advertising platform to maximize advertising revenue across multiscreen, broadcast, on-demand, and OTT viewing. In addition, the company offers client application, a multiscreen user experience product that empower service providers and content owners to optimize live and on-demand video consumption on multiscreen and OTT services. Further, it provides professional, and maintenance and technical support services, as well as managed services. The company sells and markets its products and services through a direct sales process, as well as to systems integrators and value-added resellers. It serves cable system operators, telecommunications companies, and satellite operators, as well as broadcasters and other content providers. The company was incorporated in 1993 and is headquartered in Boston, Massachusetts.

NASDAQ ended the session with SeaChange International rising 10.73% to $0.41 on Thursday while NASDAQ rose 0.76% to $12,087.96.

Earnings Per Share

As for profitability, SeaChange International has a trailing twelve months EPS of $-0.581.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.24%.

More news about SeaChange International.

6. Inovio Pharmaceuticals (INO) – 10.38%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals jumping 10.38% to $0.77 on Thursday, after three sequential sessions in a row of losses. NASDAQ rose 0.76% to $12,087.96, after three sequential sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-1.073.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -92.27%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 3038.2%, now sitting on 10.98M for the twelve trailing months.

More news about Inovio Pharmaceuticals.

7. Rubicon Technology (RBCN) – 9.59%

Rubicon Technology, Inc. provides monocrystalline sapphire for applications in optical and industrial systems in North America and Asia. The company offers optical and industrial sapphire products in various shapes and sizes, including round and rectangular windows and wafers, domes, tubes, and rods for a range of end markets comprising defense and aerospace, specialty lighting, instrumentation, sensors and detectors, semiconductor process equipment, electronic substrates, medical, and laser applications. It serves defense subcontractors, industrial manufacturers, fabricators, and resellers. The company was incorporated in 2001 and is based in Bensenville, Illinois.

NASDAQ ended the session with Rubicon Technology jumping 9.59% to $1.60 on Thursday, following the last session’s upward trend. NASDAQ jumped 0.76% to $12,087.96, after three consecutive sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Rubicon Technology has a trailing twelve months EPS of $0.35.

PE Ratio

Rubicon Technology has a trailing twelve months price to earnings ratio of 4.57. Meaning, the purchaser of the share is investing $4.57 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.64%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 20.9%, now sitting on 3.59M for the twelve trailing months.

More news about Rubicon Technology.

8. Ebix (EBIX) – 9.13%

Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, and healthcare industries in the United States and internationally. It develops and deploys insurance and reinsurance exchanges; provides software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, and front-end and back-end systems; and offers outsourced administrative and risk compliance solutions. The company operates P&C exchanges primarily in Australia, New Zealand, the United Kingdom, and the United States, which facilitates the exchange of insurance data between brokers and insurance carriers with a focus on the areas of personal and commercial lines. Its exchange related products and services include travel exchanges and money transfer services; foreign exchange and outward remittance services; payment services; gift cards for consumers that can be redeemed at various merchants; and technology services for various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setting up, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services comprising project management and development; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia.

NASDAQ ended the session with Ebix rising 9.13% to $13.09 on Thursday, after three consecutive sessions in a row of losses. NASDAQ jumped 0.76% to $12,087.96, after three sequential sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Ebix has a trailing twelve months EPS of $3.02.

PE Ratio

Ebix has a trailing twelve months price to earnings ratio of 4.33. Meaning, the purchaser of the share is investing $4.33 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.42%.

Volatility

Ebix’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.78%, a negative 1.44%, and a positive 3.12%.

Ebix’s highest amplitude of average volatility was 3.07% (last week), 3.09% (last month), and 3.12% (last quarter).

Sales Growth

Ebix’s sales growth is negative 5.9% for the current quarter and negative 12% for the next.

More news about Ebix.

9. Tilray (TLRY) – 5.94%

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.

NASDAQ ended the session with Tilray jumping 5.94% to $2.59 on Thursday while NASDAQ jumped 0.76% to $12,087.96.

Earnings Per Share

As for profitability, Tilray has a trailing twelve months EPS of $-1.639.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -11.9%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Tilray’s stock is considered to be overbought (>=80).

Moving Average

Tilray’s worth is way below its 50-day moving average of $2.88 and way below its 200-day moving average of $3.32.

More news about Tilray.

10. Matterport
(MTTR) – 5.62%

Matterport, Inc., a spatial data company, focuses on digitization and datafication of the built world. It offers Matterport digital twins, a 3D data platform to design, build, operate, promote, and understand spaces. The company offers Matterport Capture, an application that enables to capture depth, data, and imagery of a space using 3D cameras, 360 cameras, and iPhones; Matterport Workshop application to customize, add additional details, and share spaces; Matterport Showcase application for audience view and explore space in its final format; and Matterport VR to experience virtual reality. It offers solutions for real estate, photography, travel and hospitality, retail, insurance and restoration, industrial and facilities management, architecture, and engineering and construction industries. Matterport, Inc. was founded in 2011 and is headquartered in Sunnyvale, California.

NASDAQ ended the session with Matterport
rising 5.62% to $2.73 on Thursday while NASDAQ rose 0.76% to $12,087.96.

Earnings Per Share

As for profitability, Matterport
has a trailing twelve months EPS of $-3.367.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -52.24%.

Sales Growth

Matterport
‘s sales growth is 46.6% for the ongoing quarter and 39.3% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 37.4%, now sitting on 122.07M for the twelve trailing months.

Volume

Today’s last reported volume for Matterport
is 2784430 which is 7.29% below its average volume of 3003680.

Yearly Top and Bottom Value

Matterport
‘s stock is valued at $2.73 at 17:32 EST, way below its 52-week high of $9.36 and way higher than its 52-week low of $2.37.

More news about Matterport
.

Losers Today

1. Redhill Biopharma Ltd. (RDHL) – -9.47%

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis, and has completed Phase 2 studies for irritable bowel syndrome with diarrhea; and RHB-106, an encapsulated formulation for bowel preparation, which is preparing for Phase 2/3 study. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.

NASDAQ ended the session with Redhill Biopharma Ltd. dropping 9.47% to $3.25 on Thursday while NASDAQ jumped 0.76% to $12,087.96.

Earnings Per Share

As for profitability, Redhill Biopharma Ltd. has a trailing twelve months EPS of $-61.26.

Volume

Today’s last reported volume for Redhill Biopharma Ltd. is 48779 which is 67.69% below its average volume of 151014.

Moving Average

Redhill Biopharma Ltd.’s worth is way under its 50-day moving average of $7.48 and way below its 200-day moving average of $20.34.

More news about Redhill Biopharma Ltd..

2. Recon Technology, Ltd. (RCON) – -9.33%

Recon Technology, Ltd. provides hardware, software, and on-site services to companies in the petroleum mining and extraction industry in the People's Republic of China. The company offers equipment, tools, and other hardware related to oilfield production and management, and transportation; and develops and sells industrial automation control and information solutions. It also provides equipment for oil and gas production and transportation, including heating furnaces and burner, as well as enhancing techniques comprising packers of fracturing; production packers; sand prevention in oil and water wells; water locating and plugging techniques; fissure shaper; fracture acidizing techniques; and electronic broken-down services to resolve block-up and freezing problems. In addition, the company offers automation systems and services, including pumping unit controller that monitors the pumping units and collects data; RTU to monitor natural gas wells and collect gas well pressure data; wireless dynamometers and wireless pressure gauges; electric multi-way valves for oilfield metering station flow control; and natural gas flow computer systems. Further, it provides Recon SCADA oilfield monitor and data acquisition system for supervision and data collection; EPC service of pipeline SCADA system for pipeline monitoring and data acquisition; EPC service of oil and gas wells SCADA system for monitoring and data acquisition of oil wells and natural gas wells; EPC service of oilfield video surveillance and control system to control the oil and gas wellhead and measurement station areas; and technique service for digital oilfield transformation. Additionally, the company offers oilfield waste water treatment solutions and related chemicals; and oily sludge disposal solutions. Recon Technology, Ltd. was incorporated in 2007 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Recon Technology, Ltd. dropping 9.33% to $0.34 on Thursday while NASDAQ rose 0.76% to $12,087.96.

Earnings Per Share

As for profitability, Recon Technology, Ltd. has a trailing twelve months EPS of $-0.28.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -11.78%.

Volume

Today’s last reported volume for Recon Technology, Ltd. is 412210 which is 56.92% below its average volume of 956937.

Sales Growth

Recon Technology, Ltd.’s sales growth for the current quarter is 6.1%.

More news about Recon Technology, Ltd..

3. Quest Resource Holding Corporation (QRHC) – -7.83%

Quest Resource Holding Corporation, together with its subsidiaries, provides solutions for the reuse, recycling, and disposal of various waste streams and recyclables in the United States. It offers disposal and recycling services for motor oil and automotive lubricants, oil filters, scrap tires, oily water, goods destruction, food waste, meat renderings, cooking oil and grease trap waste, plastics, cardboard, metal, glass, mixed paper, construction debris, as well as a large variety of regulated and non-regulated solid, liquid, and gas wastes. The company provides santifreeze and windshield washer fluid, dumpster and compacting equipment, and other minor ancillary services. In addition, it offers landfill diversion services. The company's services focus on the waste streams and recyclables from big box, grocers, and other retailers; automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and internal fleet operators; manufacturing plants; multi-family and commercial properties; restaurant chains and food operations; and construction and demolition projects. It markets its services to automotive, manufacturing, hospitality and retail, construction and demolition, and commercial and multi-family property management industries through direct sales force and strategic partnerships. The company was formerly known as Infinity Resources Holdings Corp. and changed its name to Quest Resource Holding Corporation in October 2013. Quest Resource Holding Corporation was incorporated in 2002 and is based in The Colony, Texas.

NASDAQ ended the session with Quest Resource Holding Corporation falling 7.83% to $5.65 on Thursday while NASDAQ jumped 0.76% to $12,087.96.

Earnings Per Share

As for profitability, Quest Resource Holding Corporation has a trailing twelve months EPS of $-0.32.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.35%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 45.5% and a drop 120% for the next.

More news about Quest Resource Holding Corporation.

4. Super Micro Computer (SMCI) – -7.38%

Super Micro Computer, Inc., together with its subsidiaries, develops and manufactures high-performance server and storage solutions based on modular and open architecture. Its solutions range from complete server, storage, modular blade servers, blades, workstations, full racks, networking devices, server management software, and server sub-systems, as well as security software. The company also provides application-optimized server solutions, including rackmount and blade servers, storage systems, and subsystems and accessories; and server software management solutions, such as Server Management Suite, including Supermicro Server Manager, Supermicro Power Management software, Supermicro Update Manager, SuperCloud Composer, and SuperDoctor 5. In addition, it offers server subsystems and accessories comprising server boards, chassis, power supplies, and other accessories. Further, the company provides server and storage system integration, configuration, and software upgrade and update services; and technical documentation services, as well as identifies service requirements, creates and executes project plans, and conducts verification testing and training services. Additionally, it offers help desk and on-site product support services for its server and storage systems; and customer support services, including ongoing maintenance and technical support for its products. The company provides its products to enterprise data centers, cloud computing, artificial intelligence, and 5G and edge computing markets. It sells its products through direct and indirect sales force, distributors, value-added resellers, system integrators, and original equipment manufacturers. The company primarily operates in the United States, Europe, Asia, and internationally. Super Micro Computer, Inc. was incorporated in 1993 and is headquartered in San Jose, California.

NASDAQ ended the session with Super Micro Computer falling 7.38% to $100.06 on Thursday, after two successive sessions in a row of losses. NASDAQ jumped 0.76% to $12,087.96, after three consecutive sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Super Micro Computer has a trailing twelve months EPS of $11.17.

PE Ratio

Super Micro Computer has a trailing twelve months price to earnings ratio of 8.96. Meaning, the purchaser of the share is investing $8.96 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.49%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is 28.4% and a drop 23.3% for the next.

More news about Super Micro Computer.

5. Aspen Group (ASPU) – -7.11%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group sliding 7.11% to $0.06 on Thursday while NASDAQ rose 0.76% to $12,087.96.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.383.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.28%.

Yearly Top and Bottom Value

Aspen Group’s stock is valued at $0.06 at 17:32 EST, way below its 52-week high of $1.39 and way higher than its 52-week low of $0.03.

Volatility

Aspen Group’s last week, last month’s, and last quarter’s current intraday variation average was a positive 18.51%, a negative 1.65%, and a positive 8.21%.

Aspen Group’s highest amplitude of average volatility was 27.87% (last week), 12.92% (last month), and 8.21% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 9.9%, now sitting on 74.29M for the twelve trailing months.

More news about Aspen Group.

6. Signature Bank (SBNY) – -5.54%

Signature Bank provides commercial banking products and services. It accepts various deposit products, including checking accounts, money market accounts, escrow deposit accounts, cash concentration accounts, certificates of deposit, and other cash management products. The company provides various lending products comprising commercial and industrial loans, real estate loans, and letters of credit. In addition, it offers asset management and investment products; and retirement products, such as individual retirement accounts and administrative services for retirement vehicles. Further, the company provides wealth management services to its high net worth personal clients; and purchases, sells, and assembles small business administration loans and pools. Additionally, it offers individual and group insurance products, including health, life, disability, and long-term care insurance products for business and private clients. As of December 31, 2021, the company operated 37 private client offices located in the metropolitan New York area, Connecticut, California, and North Carolina. Signature Bank was incorporated in 2000 and is headquartered in New York, New York.

NASDAQ ended the session with Signature Bank dropping 5.54% to $0.16 on Thursday, after five sequential sessions in a row of losses. NASDAQ rose 0.76% to $12,087.96, after three consecutive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Signature Bank has a trailing twelve months EPS of $20.76.

PE Ratio

Signature Bank has a trailing twelve months price to earnings ratio of 0.01. Meaning, the purchaser of the share is investing $0.01 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.87%.

More news about Signature Bank.

7. Schnitzer Steel Industries (SCHN) – -5.37%

Schnitzer Steel Industries, Inc. recycles ferrous and nonferrous metal, and manufactures finished steel products worldwide. The company acquires, processes, and recycles salvaged vehicles, rail cars, home appliances, industrial machinery, manufacturing scrap, and construction and demolition scrap. It offers recycled ferrous metal, a feedstock used in the production of finished steel products; and nonferrous products, including mixed metal joint products recovered from the shredding process, such as zorba, zurik, aluminum, copper, stainless steel, nickel, brass, titanium, lead, and high temperature alloys. The company also procures salvaged vehicles and sells serviceable used auto parts from these vehicles through its 50 self-service auto parts stores in the United States and Western Canada, as well as sells auto bodies. In addition, it produces various finished steel products using ferrous recycled metal and other raw materials, as well as semi-finished goods, which include billets; and finished goods consisting of rebar, coiled rebar, wire rods, merchant bars, and other specialty products. Further, the company sells catalytic converters to specialty processors that extract the nonferrous precious metals, including platinum, palladium, and rhodium; ferrous and nonferrous recycled metal products to steel mills, foundries, refineries, smelters, wholesalers, and recycled metal processors; and finished steel customers are primarily steel service centers, construction industry subcontractors, steel fabricators, wire drawers, and major farm and wood products suppliers. Schnitzer Steel Industries, Inc. was founded in 1906 and is headquartered in Portland, Oregon.

NASDAQ ended the session with Schnitzer Steel Industries sliding 5.37% to $28.70 on Thursday, after two sequential sessions in a row of losses. NASDAQ rose 0.76% to $12,087.96, after three successive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Schnitzer Steel Industries has a trailing twelve months EPS of $3.53.

PE Ratio

Schnitzer Steel Industries has a trailing twelve months price to earnings ratio of 8.13. Meaning, the purchaser of the share is investing $8.13 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.9%.

More news about Schnitzer Steel Industries.

8. Avidity Biosciences (RNA) – -4.91%

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

NASDAQ ended the session with Avidity Biosciences sliding 4.91% to $13.55 on Thursday while NASDAQ rose 0.76% to $12,087.96.

Earnings Per Share

As for profitability, Avidity Biosciences has a trailing twelve months EPS of $-2.45.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36.27%.

Sales Growth

Avidity Biosciences’s sales growth is 13.6% for the current quarter and negative 6.3% for the next.

More news about Avidity Biosciences.

9. The Simply Good Foods Company (SMPL) – -4.78%

The Simply Good Foods Company operates as a consumer packaged food and beverage company in North America and internationally. The company develops, markets, and sells snacks and meal replacements. It offers primarily nutrition bars, ready-to-drink (RTD) shakes, sweet and salty snacks, protein bars, cookies, pizza, protein chips, recipes, and confectionery products, as well as licensed frozen meals under the Atkins, Atkins Endulge, and Quest brand names. The company distributes its products to various retail channels, such as mass merchandise, grocery and drug channels, club stores, convenience stores, gas stations, and other channels. It also sells its products through e-commerce channels, including atkins.com, questnutrition.com, and amazon.com. The Simply Good Foods Company is headquartered in Denver, Colorado.

NASDAQ ended the session with The Simply Good Foods Company dropping 4.78% to $36.84 on Thursday, after three sequential sessions in a row of losses. NASDAQ jumped 0.76% to $12,087.96, after three sequential sessions in a row of losses, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, The Simply Good Foods Company has a trailing twelve months EPS of $0.7.

PE Ratio

The Simply Good Foods Company has a trailing twelve months price to earnings ratio of 52.7. Meaning, the purchaser of the share is investing $52.7 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.22%.

More news about The Simply Good Foods Company.

10. SunPower Corporation (SPWR) – -4.48%

SunPower Corporation delivers solar solutions worldwide. It operates through Residential, Light Commercial; Commercial and Industrial Solutions; and Others segments. The company provides solar energy solutions, including sales to its third-party dealer network and resellers, storage solutions, cash and loan sales, and long-term leases directly to end customers; and sells turn-key engineering, procurement, and construction services, as well as sells energy under power purchase agreements. It also offers commercial roof, carport, and ground mounted systems; and post-installation operations and maintenance services. In addition, the company provides residential leasing program services, as well as sells inverters manufactured by third parties. The company also serves investors, financial institutions, project developers, electric utilities, independent power producers, commercial and governmental entities, production home builders, residential owners, and small commercial building owners. The company was incorporated in 1985 and is headquartered in San Jose, California. SunPower Corporation is a subsidiary of Total Energies Nouvelles Activités USA.

NASDAQ ended the session with SunPower Corporation sliding 4.48% to $12.57 on Thursday, following the last session’s downward trend. NASDAQ rose 0.76% to $12,087.96, after three sequential sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, SunPower Corporation has a trailing twelve months EPS of $2.48.

PE Ratio

SunPower Corporation has a trailing twelve months price to earnings ratio of 5.07. Meaning, the purchaser of the share is investing $5.07 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.17%.

Moving Average

SunPower Corporation’s worth is way below its 50-day moving average of $15.02 and way under its 200-day moving average of $19.39.

Volume

Today’s last reported volume for SunPower Corporation is 1433110 which is 67.82% below its average volume of 4453970.

Yearly Top and Bottom Value

SunPower Corporation’s stock is valued at $12.57 at 17:32 EST, way under its 52-week high of $28.42 and higher than its 52-week low of $12.03.

More news about SunPower Corporation.

Stay up to date with our winners and losers daily report